Cargando…

Abnormal MDMX degradation in tumor cells due to ARF deficiency

MDMX is a hetero dimeric partner of MDM2 and a critical regulator of p53. MDMX level is generally elevated in tumors with wild type p53 and contributes to p53 inactivation. MDMX degradation is controlled in part by MDM2-mediated ubiquitination. Here we show that MDMX turnover is highly responsive to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaolong, Gilkes, Daniele, Li, Baozong, Cheng, Qian, Pernazza, Daniele, Lawrence, Nicholas, Chen, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290737/ https://www.ncbi.nlm.nih.gov/pubmed/22120712 http://dx.doi.org/10.1038/onc.2011.534

Ejemplares similares

Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression
por: Chen, Si, et al.
Publicado: (2022)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Is MDMX the better target?
por: Kon, Ning, et al.
Publicado: (2018)

The ion channel TRPM7 regulates zinc-depletion-induced MDMX degradation
por: Wang, Herui, et al.
Publicado: (2021)

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
por: Yu, De-Hua, et al.
Publicado: (2020)

MDMX phosphorylation-dependent p53 downregulation contributes to an immunosuppressive tumor microenvironment
por: Wang, Bing, et al.
Publicado: (2020)

Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient mice
por: Herranz, Sandra, et al.
Publicado: (2012)

MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke
por: Yan, Haomin, et al.
Publicado: (2022)

Functions of MDMX in the Modulation of the p53-Response
por: Lenos, Kristiaan, et al.
Publicado: (2011)

MDM4 (MDMX) and its Transcript Variants
por: Mancini, F, et al.
Publicado: (2009)

Role of Mdm2 and Mdmx in DNA repair
por: Eischen, Christine M.
Publicado: (2017)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Chemical Instability and Promiscuity of Arylmethylidenepyrazolinone-Based MDMX Inhibitors
por: Stefaniak, Jakub, et al.
Publicado: (2018)

New insight into the role of MDMX in MDM2-mediated p53 degradation and anti-cancer drug development
por: Yang, Jing, et al.
Publicado: (2021)

Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
por: Kon, Ning, et al.
Publicado: (2018)

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB
por: Hernández-Monge, Jesús, et al.
Publicado: (2016)

α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53–MDM2/MDMX Protein–Protein Interactions
por: Sang, Peng, et al.
Publicado: (2020)

Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
por: Chen, Yingxiao, et al.
Publicado: (2016)

Correction to α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53–MDM2/MDMX Protein–Protein Interactions
por: Sang, Peng, et al.
Publicado: (2020)

Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
por: Li, Xiang, et al.
Publicado: (2021)

MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
por: Venkatesh, Divya, et al.
Publicado: (2020)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis
por: Gao, Chong, et al.
Publicado: (2019)

Mdmx promotes genomic instability independent of p53 and Mdm2
por: Carrillo, Alexia M., et al.
Publicado: (2014)

Targeting Mdmx to treat breast cancers with wild-type p53
por: Haupt, S, et al.
Publicado: (2015)

Mouse modelling of the MDM2/MDMX−p53 signalling axis
por: Tackmann, Nicole R., et al.
Publicado: (2017)

The MDM2/MDMX/p53 axis in the adaptive stress response
por: Wang, Bing, et al.
Publicado: (2020)

The roles and regulation of MDM2 and MDMX: it is not just about p53
por: Klein, Alyssa M., et al.
Publicado: (2021)

MDM2-Mediated Degradation of p14ARF: A Novel Mechanism to Control ARF Levels in Cancer Cells
por: Vivo, Maria, et al.
Publicado: (2015)

Synthesis and Biological Evaluation of Novel Synthetic Indolone Derivatives as Anti-Tumor Agents Targeting p53-MDM2 and p53-MDMX
por: Wang, Yali, et al.
Publicado: (2022)

Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations
por: Yu, Qiong, et al.
Publicado: (2014)

Leveraging the multivalent p53 peptide-MdmX interaction to guide the improvement of small molecule inhibitors
por: Cheng, Xiyao, et al.
Publicado: (2022)

Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
por: Gao, Chong, et al.
Publicado: (2019)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

The alternative translated MDMX(p60) isoform regulates MDM2 activity
por: Tournillon, Anne-Sophie, et al.
Publicado: (2015)

Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies
por: Heijkants, R. C., et al.
Publicado: (2018)

Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53
por: Chan, Jane Vin, et al.
Publicado: (2017)

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020)

GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF
por: Lee, Sun, et al.
Publicado: (2016)

Insight Into the Binding Mechanism of p53/pDIQ-MDMX/MDM2 With the Interaction Entropy Method
por: Li, Mengxin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4qdm0ualluc2f7l569havi6ntm